CYNK | BZYR |Big Money Still Being Made On OTC Stocks

Last week we alerted on the penny stock of Burzynski Research Institute, Inc. (BZYR) and how it had the potential to climb back towards the $1 level it traded at prior to the temporary FDA partial clinical hold on its IND for Antineoplastons A10/AS2-1 Injections. We also touched on how the under $1 shares of Virtus Oil and Gas Corp. (VOIL) could be money in the bank prior ...

Continue Reading →
0

Burzynski Research Institute (BZYR) Reignites On FDA Approaval

BZYR Stock, Burzynski Research Institute Inc.Focusing since 1967 on the isolation of various biochemicals produced by the human body as part of the body’s possible defense against cancer, the penny stock of Burzynski Research Institute, Inc. (BZYR) has exploded on the scene thanks to the efforts of CEO and President Stanislaw R. Burzynski, M.D., Ph.D. After notification that the U.S. Food and Drug Administration lifted its partial clinical hold on ...

Continue Reading →
0